More tools:Markets·Screener·Research·Chat

Molecular Partners AG American Depositary Shares (MOLN) Financial Statements

Molecular Partners AG American Depositary Shares
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG010B7DJV0
XNAS · usd
4.22▼ 0.13 (-2.99%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close4.35
Day's Range4.35 – 4.35
52-Week Range3.53 – 5.41
Volume2,166
Avg Volume1,453
Share Statistics
Shares Outstanding
Employees134
ExchangeXNAS
Listed2021-06-16
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Molecular Partners AG American Depositary Shares (MOLN)
What is Molecular Partners AG American Depositary Shares's Market Cap?
Molecular Partners AG American Depositary Shares's Market Cap is $170.4M, based on as-reported figures from SEC (XBRL) filings.
What is Molecular Partners AG American Depositary Shares's Enterprise Value?
Molecular Partners AG American Depositary Shares's Enterprise Value is $86.3M, based on as-reported figures from SEC (XBRL) filings.
What is Molecular Partners AG American Depositary Shares's Revenue (TTM)?
Molecular Partners AG American Depositary Shares's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Molecular Partners AG American Depositary Shares's Net Income (TTM)?
Molecular Partners AG American Depositary Shares's Net Income (TTM) is -$63.9M, based on as-reported figures from SEC (XBRL) filings.
What is Molecular Partners AG American Depositary Shares's Diluted EPS (TTM)?
Molecular Partners AG American Depositary Shares's Diluted EPS (TTM) is -1.58, based on as-reported figures from SEC (XBRL) filings.
What is Molecular Partners AG American Depositary Shares's Net Debt?
Molecular Partners AG American Depositary Shares's Net Debt is -$84.1M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Revenues and other income
Revenues from research and development collaborations
Total revenues and other income
Operating expenses
Research and development expenses
Selling, general and administrative expenses
Restructuring expenses
Total operating expenses
Operating result
Financial income
Financial expenses
Net finance result
Result before income taxes
Income taxes
Net result, attributable to shareholders
Items that will not be reclassified to profit or loss
Remeasurement of net pension liabilities, net of tax
Items that are or may be reclassified subsequently to profit or loss
Exchange differences on translating foreign operations
Other comprehensive result, net of tax
Total comprehensive result, attributable to shareholders
Basic net result per share (in CHF per share)
Diluted net result per share (in CHF per share)